Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma

Barbara Jezeršek Novaković, Lučka Boltežar, Aleksander NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, 1000, SloveniaCorrespondence: Barbara Jezeršek NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Zaloška 2,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jezeršek Novaković B, Boltežar L, Novaković A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
pixantrone
b-cell non-hodgkin lymphomas
efficacy
toxicity
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/a7a07d97bfa349708902b90ce5f124bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a7a07d97bfa349708902b90ce5f124bc

Ejemplares similares